Queen’s University Belfast has been crowned the winner of the All-Ireland Interprofessional Healthcare Challenge for Students 2022.
Roisín O’Hare, Lead Teacher Practitioner Pharmacist of the Northern Ireland University Network, has been appointed Honorary Professor of Practice in the School of Pharmacy at Queen’s
A couple of weeks ago we celebrated National Postdoc Appreciation Week (20th – 24th September), an opportunity to reflect on the significant contributions that postdocs make to research.
Queen’s students are continuing to work together to support individuals infected with SARS-CoV2 and to protect wider society from the consequences of the Covid-19 disease.
Qubis, the commercialisation arm of Queen’s, co-invested along side NI-based investors, and three major US-based ophthalmic venture capital firms
Researchers from Queen’s University Belfast have discovered that bacteria often found in the lungs became more harmful and caused increased inflammation when they were exposed to e-cigarette vape.
People from both sides of the border will benefit from new health and social care research trials thanks to a new Cross-Border Healthcare Intervention Trials in Ireland Network (CHITIN).
Top Queen’s University PhD students Erin Magee and Nathan Clarke received scholarships of £2,500 each to support their exciting and potentially far-reaching research projects.
The Undergraduate Awards (UA) has announced the winners of the 2016 programme, including the Regional Winners and Highly Commended Entrants from Queen's University Belfast
Two former Queen's University Belfast MPharm graduates were recently given the opportunity to present their work at the Royal Pharmaceutical Society (RPS) Conference in Birmingham on the 4th and 5th September 2016.
A ground-breaking programme of work led by Dr Lorraine Martin, and funded by the Cystic Fibrosis Trust, UK has recently been published in the prestigious American Journal of Respiratory and Critical Care Medicine.
Researchers at the School of Pharmacy at Queen’s University Belfast are leading a €50 million, Europe-wide, project to develop new drug treatments that could improve the lives of patients with cystic fibrosis and bronchiectasis.